Global venture capital firm with a focus on early and growth-stage technology companies.
Verified emails & LinkedIn for founders across this portfolio.
MedicSen is a start-up dedicated to health care, to technological innovation as a key tool.
Omegga develops invasive in-ovo-sexing technology to prevent the killing of 7 billion male laying hens.
Casinvent Pharma develops therapeutic options for the treatment of selected malignancies.
Medical Technology, Medical Technology
Proteotype Diagnostics providing cross-sectional snapshots, like a CT scan for your blood.
Exogenus Therapeutics develops cellular based therapies applied to regenerative medicine for skin lesions treatment.
Quantum SaaS for Market Risk Management for Financial Institutions
SafePAS is a soil nutrients analyzer and SaaS platform to manage fertilizer usage to increase soil health and crop yield.
UP Catalyst produces sustainable carbon nanomaterials and graphite for the green energy storage industry.
Biotts develop proprietary drug delivery technologies and drug formulas in the field of diabetology.
Fetalix offers a regenerative fetal-inspired biomaterial aimed at treating Low Back Pain (LBP) through a minimally invasive procedure.
ResQuant develops fully flexible design of cryptographic processor resistant to attacks with quantum computers.
DIANA Biotechnologies specializes in the development of products based on research in clinical diagnostics and drug discovery areas.
IoT, Biotechnology, Software and Hardware Development
Orbital Matter is a construction company in space that works on a 3D printing technology to be used directly in orbit and on the moon.
Solar Materials offers photovoltaic modules recycling services.
Orange Quantum Systems develops hardware and software solutions for testing and characterizing quantum chip performance.
Multi4 is the world's first company to successfully develop automated technologies for the diagnosis and treatment of endoscopic cancer.
Solmeyea produces single-cell proteins from CO2 for food applications, aiming at CO2 circularity and addressing climate issues.
SUBRA A/S focuses on innovation, industrial-scale production, and creating a sustainable impact.
MultiplexDX is a biotechnology research firm that focuses on development of the technologies and products for molecular diagnostic markets.
With everything we do, we aim to harness sustainable energy in order to energize the future.
Nature Robots develops modular autonomy software and hardware for AI-powered, GNSS-independent autonomous farming in complex environments.
Captor Therapeutics is a bio-pharmaceutical firm focused on development of protein degradation drugs for cancer and autoimmune diseases.
EIC Accelerator has invested in 337 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
EIC Accelerator's top investment sectors include Biotechnology, Medical, Manufacturing, Health Care, Pharmaceutical. The firm invests across 42 different industry categories.
Among tracked funding rounds, SUBRA A/S received $46.9M in a Series A round. EIC Accelerator's total known invested capital is $1.8B.
EIC Accelerator's average investment size is $5.5M across its portfolio of 337 companies.
Recent EIC Accelerator portfolio additions include MedicSen, Omegga GmbH, Casinvent Pharma, SIM4FLOW, Proteotype Diagnostics. These companies were founded in 2020 or later.